Your session is about to expire
← Back to Search
20 Botox Injections for Overactive Bladder
Study Summary
This trial is testing whether 10 injections of Botox is less painful and just as effective as 20 injections for treating urge incontinence.
- Overactive Bladder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there any risk associated with receiving twenty doses of Botox?
"The safety of 20 Botox Injections has been assessed and given a rating of 3 due to its approval as part of Phase 4 clinical trials."
To what extent are 20 Botox Injections utilized in medical treatments?
"Botox injections are a popular method of managing urinary incontinence. 20 Botox Injections can also treat other medical issues such as spinal cord injury, botulism, and overactive bladder syndrome (OABs)."
Are participants over 25 years of age eligible for this experiment?
"Individuals aged 18 to 90 years old are being considered for this trial."
What precedent has been set with regard to 20 Botox Injections in other clinical trials?
"As of now, 61 medical trials for 20 Botox Injections are being conducted with a significant portion in their third phase. Of these studies, most are based out of Farmington Hills, Michigan but have spread to 759 other locations as well."
Are there any vacancies in this medical experiment for participants?
"As outlined on clinicaltrials.gov, this medical trial is currently enrolling participants. The research was initially made public on November 10th 2019 with the latest update taking place in August 23rd 2022."
How many participants are receiving treatment as part of this research?
"Affirmative. According to the clinicaltrials.gov website, this medical research project is actively seeking participants and was last updated on August 23rd 2022; it originally posted on November 10th 2019. The study seeks 40 patients from two locations."
What are the qualifications for enrolling in this clinical research trial?
"This clinical trial has 40 openings for female participants, aged 18-90 with an overactive detrusor. The enrollees must be willing to learn or have a care provider perform intermittent catheterization, accept Botox® injections as treatment for refractory OAB and understand that they need to complete the required questionnaires throughout their follow up sessions after giving informed consent."
Share this study with friends
Copy Link
Messenger